Ohr Pharmaceutical Provides Update on Ongoing Squalamine Clinical Trial in Wet-AMD
April 10, 2017 16:15 ET
|
Ohr Pharmaceutical, Inc.
Results from Ongoing Clinical Trial in Wet-AMD (The MAKO Study) Expected by the End of Calendar 2017 or Early 2018Company Now Fully Funded Through Efficacy Data From Ongoing Trial and Into 2018 NEW...
Ohr Pharmaceutical Announces Closing of Public Offering of Common Stock and Warrants
April 10, 2017 16:01 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, April 10, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that it has closed its previously announced...
Ohr Pharmaceutical Announces Pricing of $14.175 Million Public Offering of Common Stock and Warrants
April 05, 2017 09:22 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, April 05, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that it has priced a registered public...
Ohr Pharmaceutical Announces Proposed Public Offering of Common Stock and Warrants
April 04, 2017 16:01 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, April 04, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that it intends to offer shares of its common...
Ohr Pharmaceutical to Present at the Cowen & Company 37th Annual Health Care Conference
March 02, 2017 09:38 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, March 02, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that...
Ohr Pharmaceutical Announces Strategic Update and Fiscal First Quarter 2017 Earnings
February 14, 2017 07:00 ET
|
Ohr Pharmaceutical, Inc.
Management to Host a Conference Call and Webcast at 7:45a.m Eastern Time Today NEW YORK, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical...
Ohr Pharmaceutical to Announce First Quarter 2017 Financial Results on February 14
February 13, 2017 10:32 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Feb. 13, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that it will report financial results for its...
Ohr Pharmaceutical Reports Fiscal Year 2016 Financial and Business Results
December 22, 2016 16:01 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Dec. 22, 2016 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today reported results for its fourth quarter and fiscal year...
Ohr Pharmaceutical to Announce Fourth Quarter and Fiscal 2016 Financial Results on December 22
December 15, 2016 14:10 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Dec. 15, 2016 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that it will report financial results for the...
Ohr Pharmaceutical Announces Closing of Public Offering of Common Stock and Warrants
December 14, 2016 08:00 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Dec. 14, 2016 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that it has closed its previously announced...